Education
About Us
Working with TipRanks
Follow Us
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.70M | $ 12.06M | $ 12.75M | $ 11.78M | $ 11.16M |
| Gross Profit | $ 2.70M | $ 2.55M | $ 3.30M | $ -381.00K | $ 4.46M |
| Operating Income | $ -35.31M | $ -54.03M | $ -62.80M | $ -71.56M | $ -63.70M |
| EBITDA | $ -33.57M | $ -49.77M | $ -55.80M | $ -59.59M | $ -59.66M |
| Net Income | $ -50.05M | $ -61.62M | $ -62.49M | $ -77.70M | $ -78.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 16.30M | $ 13.22M | $ 45.56M | $ 63.62M | $ 68.27M |
| Total Assets | $ 28.56M | $ 31.37M | $ 65.02M | $ 83.05M | $ 93.42M |
| Total Debt | $ 66.58M | $ 39.22M | $ 77.54M | $ 111.11M | $ 149.98M |
| Net Debt | $ 51.48M | $ 27.08M | $ 42.63M | $ 71.22M | $ 114.20M |
| Total Liabilities | $ 84.60M | $ 51.25M | $ 87.28M | $ 118.12M | $ 156.24M |
| Stockholders' Equity | $ -56.04M | $ -19.89M | $ -22.26M | $ -35.07M | $ -62.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -24.70M | $ -41.23M | $ -49.28M | $ -47.93M | $ -51.76M |
| Operating Cash Flow | $ -24.19M | $ -40.20M | $ -48.73M | $ -47.32M | $ -50.39M |
| Investing Cash Flow | $ -509.00K | $ 8.66M | $ 12.42M | $ 8.30M | $ 13.61M |
| Financing Cash Flow | $ 27.05M | $ 9.02M | $ 31.63M | $ 43.23M | $ 11.63M |
Accelerate Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.